Acadian Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,617
| Closed | -$149K | – | 2328 |
|
|
2021
Q1 | $149K | Sell |
1,617
-311,851
| -99% | -$28.7M | ﹤0.01% | 1576 |
|
|
2020
Q4 | $22.9M | Sell |
313,468
-7,465
| -2% | -$546K | 0.09% | 194 |
|
|
2020
Q3 | $24.9M | Sell |
320,933
-18,955
| -6% | -$1.47M | 0.1% | 178 |
|
|
2020
Q2 | $18.9M | Sell |
339,888
-8,790
| -3% | -$489K | 0.08% | 221 |
|
|
2020
Q1 | $10.3M | Sell |
348,678
-122,181
| -26% | -$3.62M | 0.06% | 253 |
|
|
2019
Q4 | $17M | Sell |
470,859
-330,592
| -41% | -$12M | 0.08% | 223 |
|
|
2019
Q3 | $21.8M | Buy |
801,451
+39,194
| +5% | +$1.07M | 0.09% | 199 |
|
|
2019
Q2 | $18.3M | Buy |
762,257
+140,309
| +23% | +$3.38M | 0.09% | 200 |
|
|
2019
Q1 | $16.4M | Buy |
621,948
+296,762
| +91% | +$7.84M | 0.07% | 216 |
|
|
2018
Q4 | $6.35M | Buy |
325,186
+161,738
| +99% | +$3.16M | 0.03% | 340 |
|
|
2018
Q3 | $3.2M | Buy |
+163,448
| New | +$3.2M | 0.01% | 459 |
|
|
2017
Q4 | – | Sell |
-496
| Closed | -$6K | – | 1742 |
|
|
2017
Q3 | $6K | Buy |
+496
| New | +$6K | ﹤0.01% | 1330 |
|
|
2017
Q2 | – | Sell |
-377
| Closed | -$6K | – | 1702 |
|
|
2017
Q1 | $6K | Sell |
377
-22,000
| -98% | -$350K | ﹤0.01% | 1477 |
|
|
2016
Q4 | $363K | Buy |
22,377
+17,910
| +401% | +$291K | ﹤0.01% | 928 |
|
|
2016
Q3 | $80K | Buy |
4,467
+3,843
| +616% | +$68.8K | ﹤0.01% | 1093 |
|
|
2016
Q2 | $11K | Buy |
624
+44
| +8% | +$776 | ﹤0.01% | 1221 |
|
|
2016
Q1 | $10K | Buy |
+580
| New | +$10K | ﹤0.01% | 1201 |
|